Skip to Content

Join the 'Hypogonadism' group to help and get support from people like you.

Hypogonadism News

FDA Approves Aveed (testosterone undecanoate) Injectable Testosterone Replacement Therapy

Posted 6 Mar 2014 by Drugs.com

DUBLIN, March 6, 2014 /PRNewswire/ – Endo International plc announced today that its operating company Endo Pharmaceuticals Inc. received U.S. Food and Drug Administration (FDA) approval of Aveed (testosterone undecanoate) injection for the treatment of adult men with hypogonadism (commonly known as Low-T) that is associated with a deficiency or absence of the male hormone testosterone. Aveed is a new prescription medicine indicated to produce serum testosterone levels in the normal range by administration of a single 3-mL (750 mg) intramuscular injection given once at initiation of therapy, at 4 weeks, and then every 10 weeks thereafter. It is expected to be available in early March. "Today's FDA approval of Aveed is a significant milestone for Endo. Aveed expands our branded portfolio of men's health products and highlights our passion and commitment to providing high quality ... Read more

Related support groups: Testosterone, Hypogonadism, Hypogonadism - Male, Low T

Ask a Question

Further Information

Related Condition Support Groups

Hypogonadism - Male